 |
 |
Peter J. WerthBoard MemberPeter J. Werth, is CEO, President and founder of ChemWerth Inc., a privately held Connecticut based corporation founded in 1982 to develop active pharmaceutical ingredients (API) used to produce generic drugs. ChemWerth has operations in China and India. Mr. Werth has worked in the chemical side of the generic drug business from its inception in 1975 in the areas of Research & Development and Sales and Marketing. From 1965 to 1975, he worked in R & D for Upjohn Pharmaceuticals (now Pfizer). His last position prior to starting ChemWerth was with Ganes Chemicals, a subsidiary of Siegfried Chemicals, where he held the position of Vice President of Sales and Marketing of their US operations. Mr. Werth’s first business trip to China was in 1979. ChemWerth was one of the first companies to recognize China's potential to be a major supplier of generic APIs to the USA. By 1986, ChemWerth received FDA approval for its first product from China. Mr. Werth earned a BS degree in Chemistry and Math from Kansas State College, and an MS degree in Organic Chemistry from Stanford University. Besides InnoPharma, Mr Werth is on the Board of Directors of Scidose LLC, University of Connecticut R & D Corporation, and VMD discovery LLC. He has formed three of his own LLCs to develop commercial projects using specific technologies. Mr. Werth along with his wife, established the Werth Family Foundation to support various philanthropic causes. |
 AppreciationPublic Information - BEIP Activity ReportBusiness Employment Incentive Program (BEIP) Activity Click here for a list of all executed BEIP grants (alphabetically). |
| Home |About Us|Management Team|Board Of Directors|Scientific Advisory Board| News Releases|Careers| Contact Us | |||||
| © 2011 by InnoPharma, Inc. All rights reserved. Terms of use | Privacy disclaimers | EEO notice | |||||